Zoetis | ZTS - Ebitda

Aktienkurs
74.22
Täglich Wechseln
-1.26 -1.67%
Monatlich
-37.65%
Jährlich
-54.48%
Q2 Prognose
72.73




Ebitda Veränderung Datum
AbbVie USD 5.37B 1.85B 2025-12
Align Technology USD 260.87M 77.03M 2025-12
Bayer EUR 4.45B 2.49B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Charles River Laboratories USD 229.8M 28.26M 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Dentsply International USD 129M 6M 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Henry Schein USD 289M 2M 2026-03
Idexx Laboratories USD 400.87M 45.95M 2026-03
Illumina USD 469M 137M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 605.6M 17.5M 2026-03
Merck USD 6.3B 2.09B 2025-12
Neogen USD 48.2M 546K 2025-12
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Phibro Animal Health USD 68.1M 6.2M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Sanofi EUR 3.31B 3.65B 2026-03
Sanofi EUR 5.66B 3.77B 2025-09
Zoetis USD 939M 101M 2025-12